A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

NCT00035061 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Urologic Neoplasms
Metastases, Neoplasm

Interventions

DRUG: pemetrexed

Sponsor

Eli Lilly and Company